Effect of Daikenchuto (TJ-100) on Postoperative Bowel Motility and on Prevention of Paralytic Ileus after Pancreaticoduodenectomy: A Multicenter, Randomized, Placebo-controlled Phase II Trial (The JAPAN-PD Study)

Author： Okada Ken-ichi   Kawai Manabu   Uesaka Katsuhiko   Kodera Yasuhiro   Nagano Hiroaki   Murakami Yoshiaki   Morita Satoshi   Sakamoto Junichi   Yamaue Hiroki  

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.4, 2013-04, pp. : 436-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of gabapentin on postoperative pain: A randomized, placebo-controlled clinical study

By Tuncer Sema   Bariskaner Hulagu   Reisli Ruhiye   Sarkilar Gamze   Çicekci Faruk   Otelcioglu Seref  

The Pain Clinic, Vol. 17, Iss. 1, 2005-03 ,pp. : 95-99

Maney Publishing

Access to resources Recommend Favorite

Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial

By Rastelli Antonella   Taylor Marie   Gao Feng   Armamento-Villareal Reina   Jamalabadi-Majidi Shohreh   Napoli Nicola   Ellis Matthew  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

By Kono Toru   Hata Taishi   Morita Satoshi   Munemoto Yoshinori   Matsui Takanori   Kojima Hiroshi   Takemoto Hiroyoshi   Fukunaga Mutsumi   Nagata Naoki   Shimada Mitsuo   Sakamoto Junichi   Mishima Hideyuki  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1283-1290

Springer Publishing Company

Access to resources Recommend Favorite

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian Cancer

By Roberts J.A.   Jenison E.L.   Kim K.   Clarke-Pearson D.   Langleben A.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

By Eatock M. M.   Tebbutt N. C.   Bampton C. L.   Strickland A. H.   Valladares-Ayerbes M.   Swieboda-Sadlej A.   Van Cutsem E.   Nanayakkara N.   Sun Y.-N.   Zhong Z. D.   Bass M. B.   Adewoye A. H.   Bodoky G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 710-718

Oxford University Press

Access to resources Recommend Favorite